{"@id":"https://bioecon.ru/technology/peptide-drug-conjugates-via-cspg4/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/peptide-drug-conjugates-via-cspg4/","json":"https://en.bioecon.ru/api/v1/technology/peptide-drug-conjugates-via-cspg4/index.json"},"id":"peptide-drug-conjugates-via-cspg4","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/a-costantino-c-spa/","https://bioecon.ru/companies/isomerase/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/isomorphic-labs/"]},"maturity":6,"name":"CSPG4-Targeted Peptide-Drug Conjugates","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"High-affinity cyclic peptide design"},{"n":2,"title":"Cathepsin-cleavable linker chemistry"},{"n":3,"title":"Endocytic internalization kinetics"},{"n":4,"title":"Solid tumor anti-vascular response"}],"summary":"Engineered cyclic peptides targeting chondroitin sulfate proteoglycan 4 (CSPG4) to induce rapid receptor-mediated endocytosis of cytotoxic agents in melanoma and triple-negative breast cancer.","url":"/technology/peptide-drug-conjugates-via-cspg4/","verified":"2026-11-22"}